Serum Magnesıum and Intra-Erythrocyte Magnesıum Levels in Patıents with Acute Myocardıal Infarctus

Introduction: In this study, we intended to commentate on whether serum-Magnesium (S-Mg') and intra-erythrocytic-Magnesium (Ie-Mg'*) levels are a risk factor for acute myocardial infarction in patients diagnosed with acute myocardial infarction (AMI). Materials and Methods: The study included 57 (44 Male, 13 Female) patients with acute myocardial infarction and 35 control cases (23 Male, 12 Female) who did not have any coronary artery disease and did not use any medication affecting Magnesium (Mg) levels. Blood samples were taken from the patients included in the study and the individuals in the control group to measure S-Mg and Ie-Mg levels. In addition, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), and total cholesterol (Total-C) levels of both the patient and control groups were measured. The patient and control groups were compared in terms of serum and intra-erythrocytic Mg levels. Besides, it was also examined whether there was a statistical correlation between the S-Mg' and Ie-Mg” levels of the patient and control groups and age, gender, and smoking. Findings: While S-Mg* levels were found to be significantly lower in the patient group with acute myocardial infarction, no significant difference was found between the patient and control groups in terms of Ie-Mg levels. This shows us that Mg decreases in the extracellular space in the acute phase of infarction and may be a risk factor for coronary artery disease. Additionally, we did not find any relationship between age and smoking and S-Mg' and Ie-Mg” levels in the patient group. As a result, we can propound that serum magnesium level is low in patients with AMI. Therefore, we think that using Mg* therapy after infarction may benefit these patients due to the cardioprotective properties of Mg. Within the difficulties of measuring intra- erythrocytic-Magnesium levels and because of the cost-effectivity, also there is no statistical difference between patient and control groups, it would be enough measuring of serum Mg levels to evaluate this subject.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-02-18
DOI
https://doi.org/10.5281/zenodo.18681637
Primary Topic
Magnesium in Health and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum Magnesıum and Intra-Erythrocyte Magnesıum Levels in Patıents with Acute Myocardıal Infarctus

Hakan Alagözlü, Sevki Hakan Eren, Sedat Özbay
Zenodo (CERN European Organization for Nuclear Research)
Magnesium in Health and Disease
article

Serum Magnesıum and Intra-Erythrocyte Magnesıum Levels in Patıents with Acute Myocardıal Infarctus

Hakan Alagözlü, Sevki Hakan Eren, Sedat Özbay
article en

Abstract

Introduction: In this study, we intended to commentate on whether serum-Magnesium (S-Mg') and intra-erythrocytic-Magnesium (Ie-Mg'*) levels are a risk factor for acute myocardial infarction in patients diagnosed with acute myocardial infarction (AMI). Materials and Methods: The study included 57 (44 Male, 13 Female) patients with acute myocardial infarction and 35 control cases (23 Male, 12 Female) who did not have any coronary artery disease and did not use any medication affecting Magnesium (Mg) levels. Blood samples were taken from the patients included in the study and the individuals in the control group to measure S-Mg and Ie-Mg levels. In addition, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), and total cholesterol (Total-C) levels of both the patient and control groups were measured. The patient and control groups were compared in terms of serum and intra-erythrocytic Mg levels. Besides, it was also examined whether there was a statistical correlation between the S-Mg' and Ie-Mg” levels of the patient and control groups and age, gender, and smoking. Findings: While S-Mg* levels were found to be significantly lower in the patient group with acute myocardial infarction, no significant difference was found between the patient and control groups in terms of Ie-Mg levels. This shows us that Mg decreases in the extracellular space in the acute phase of infarction and may be a risk factor for coronary artery disease. Additionally, we did not find any relationship between age and smoking and S-Mg' and Ie-Mg” levels in the patient group. As a result, we can propound that serum magnesium level is low in patients with AMI. Therefore, we think that using Mg* therapy after infarction may benefit these patients due to the cardioprotective properties of Mg. Within the difficulties of measuring intra- erythrocytic-Magnesium levels and because of the cost-effectivity, also there is no statistical difference between patient and control groups, it would be enough measuring of serum Mg levels to evaluate this subject.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 49%
Magnesium in Health and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.